factor VIII

Antitumor effect of gefitinib (‘Iressa’) on esophageal squamous cell carcinoma cell lines in vitro and in vivo

Flow Cytometry / Cell Cycle / Signal Transduction / Cell line / Humans / Cancer Therapy / Mice / Female / Animals / Kinase inhibitor / Oral Squamous Cell Carcinoma (OSCC) / Epidermal Growth Factor Receptor / Tyrosine Kinase Inhibitor / factor VIII / Growth Inhibition / Cell Proliferation / Cell Cycle Arrest / Antitumor Activity / Growth Factor / Antineoplastic Agents / Cell Sorting / Nude mice / Growth factor receptor / Quinazolines / Cancer Therapy / Mice / Female / Animals / Kinase inhibitor / Oral Squamous Cell Carcinoma (OSCC) / Epidermal Growth Factor Receptor / Tyrosine Kinase Inhibitor / factor VIII / Growth Inhibition / Cell Proliferation / Cell Cycle Arrest / Antitumor Activity / Growth Factor / Antineoplastic Agents / Cell Sorting / Nude mice / Growth factor receptor / Quinazolines

Lactobacillus casei modulates the inflammation-coagulation interaction in a pneumococcal pneumonia experimental model

Inflammation / Streptococcus pneumoniae / Clinical Sciences / Lactobacillus Casei / Mouse Model / factor VIII / Plasminogen Activator Inhibitor / Bronchoalveolar lavage / Experimental Model / factor VIII / Plasminogen Activator Inhibitor / Bronchoalveolar lavage / Experimental Model

When do we transfuse cryoprecipitate?

Fibrinogen / Humans / Internal Medicine / Clinical Sciences / Public health systems and services research / Blood Transfusion / factor VIII / Blood Transfusion / factor VIII

Combined FV and FVIII deficiency

Membrane Proteins / Rare diseases / Haemophilia / Pregnancy / Humans / Mutation / Female / Male / Plasma / Blood Coagulation / Clinical Sciences / Hemophilia A / factor VIII / Hemorrhage / General Population / Coagulants / Intracellular Transport / DNA mutational analysis / Mutation / Female / Male / Plasma / Blood Coagulation / Clinical Sciences / Hemophilia A / factor VIII / Hemorrhage / General Population / Coagulants / Intracellular Transport / DNA mutational analysis

Desaparición de inhibidor frente a factor VIII tras el tratamiento con rituximab en un paciente con hemofilia a grave

factor VIII

Copyright © 2017 DATOSPDF Inc.